Glenmark Pharmaceuticals Ltd.

GLENMARK Share PricePharmaceuticals & Drugs

₹1,975

19 (1%)

As on December 12, 2025

Exchange Scrips: BSE532296NSEGLENMARKISININE935A01035

Market Cap ₹ 55,540 Cr

P/E Ratio 53.23

Dividend Yield 0.13 %

Performance

Market performance

Open1,965.3

High1,979.7

Volumes3,59,560

Prev1,975

Low1,951.1

As on2025-12-12

Historical performance

1 Year High2,284.8

3 Year High2,284.8

5 Year High2,284.8

1 Year Low1,275.5

3 Year Low369.05

5 Year Low348.5

Fundamentals

Company Valuation

Market Cap (₹Cr)

55,540

Face Value (₹)

P/E Ratio

53.23

Dividend Yield

0.13 %

Investment Returns

1 Year

28.7%

3 Years

364.7%

5 Years

274.5%

10 Years

127.6%

Technicals

Indicators	Value	Signal
5-DMA	1,948.44	Bullish
10-DMA	1,957.04	Bullish
20-DMA	1,919.03	Bullish
50-DMA	1,894.8	Bullish
100-DMA	1,969.06	Bullish
200-DMA	1,755.2	Bullish

Shareholding Pattern

Field	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Promoters	6	6	6	6	6
Foreign Investors	---	---	---	---	---
Domestic Investors	6	6	6	6	6
Public Investors	198783	190204	192718	195053	193943
Government	4	4	4	3	3

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

Negative

Neutral

Positive

The stock has a PE ratio of 53.23.
3Y Stock Price CAGR of the stock is 65.8.
The stock has a beta of 0.6.
In the last financial year, the company had an EBITDA of ₹24651 Million.
The company generated revenue of ₹133217 Million in the previous financial year.

Glenmark Pharmaceuticals Ltd.

197519 (1%)

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1300925.5

No. of Shares: 659 (Approx)

Performance:30.1%

P/L: ₹300925.5

Top Gainers